期刊文献+

中西医防治卵巢过度刺激综合征现代研究进展 被引量:6

Prevention and treatment on ovarian hyperstimulation syndrome with integrated Chinese and western medicine
下载PDF
导出
摘要 卵巢过度刺激综合征(OHSS)是一种医源性疾病,影响妊娠成功率,甚至危及生命。该综合征的病因及发病机制尚未阐明,目前只能对症处理和支持治疗,预防和及时发现是治疗的关键。本文就近年对OHSS的预防和中西医治疗方法等研究进展做一综述。 Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic and life -threatening complication of assisted re- production treatment, having an adverse effect on pregnancy outcomes. The pathogenesis and pathophysiological signal mecha- nisms of OHSS are still unclear. Since there is no effective method to curb the development currently, symptomatic and supportive treatments are mainly used in the clinical practice. One of the most crucial treatments is to prevent and to discover the disease in time. In this article, the prevention and treatment on ovarian hyperstimulation syndrome with integrated Chinese and western med- icine in recent years are reviewed.
作者 茹雪 张昌军
出处 《中国性科学》 2012年第12期40-43,共4页 Chinese Journal of Human Sexuality
关键词 卵巢过度刺激综合征 预防 中西医治疗 综述 Ovarian hyperstimulation syndrome (OHSS) Prevention Integrated Chinese and western medicine Review
  • 相关文献

参考文献11

二级参考文献93

共引文献85

同被引文献56

  • 1Mathur RS,Akande AV,Keay SD,et al.Distinction between early and late ovarian hyperstimulation syndrome.Fertility and sterility,2000,73(5):901-907.
  • 2Golan A,Ron-el R,Herman A,et al.Ovarian hyperstimulation syndrome:an update review.Obstetrical&gynecological survey,1989,44(6):430-440.
  • 3Humaidan P,Quartarolo J,Papanikolaou EG.Preventing ovarian hyperstimulation syndrome:guidance for the clinician.Fertility and sterility,2010,94(2):389-400.
  • 4Delvigne A,Rozenberg S.Epidemiology and prevention of ovarian hyperstimulation syndrome(OHSS):a review.Human reproduction update,2002,8(6):559-577.
  • 5Swanton A,Storey L,Mcveigh E,et al.IVF outcome in women with PCOS,PCO and normal ovarian morphology.European journal of obstetrics,gynecology,and reproductive biology,2010,149(1):68-71.
  • 6Lainas GT,Kolibianakis EM,Sfontouris IA,et al.Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.Human reproduction(Oxford,England),2013,28(7):1929-1942.
  • 7Lainas TG,Sfontouris IA,Zorzovilis IZ,et al.Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF:a prospective randomised controlled trial(RCT).Human reproduction(Oxford,England),2010,25(3):683-689.
  • 8Stadtmauer LA,Sarhan A,Duran EH,et al.The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome:a prospective randomized study.Fertility and sterility,2011,95(1):216-220.
  • 9Al-inany HG,Youssef MA,Aboulghar M,et al.Gonadotrophinreleasing hormone antagonists for assisted reproductive technology.The Cochrane database of systematic reviews,2011(5):1750.
  • 10Kolibianakis EM,Schultze-mosgau A,Schroer A,et al.A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.Human reproduction(Oxford,England),2005,20(10):2887-2892.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部